dipyridamole has been researched along with Body Weight in 28 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Effects of beraprost sodium, a chemically stable prostacyclin analogue, on renal dysfunction in an experimental rat model of glomerulonephritis were investigated." | 7.71 | Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model. ( Kurumatani, H; Matsushita, T; Sasaki, R; Sato, N; Suzuki, M; Tamura, M; Yamada, M, 2002) |
| "Furthermore." | 5.30 | Valsartan and coronary haemodynamics in early post-myocardial infarction in rats. ( De Gasparo, M; Fornes, P; Gervais, M; Giudicelli, JF; Richer, C, 1999) |
| "Effects of beraprost sodium, a chemically stable prostacyclin analogue, on renal dysfunction in an experimental rat model of glomerulonephritis were investigated." | 3.71 | Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model. ( Kurumatani, H; Matsushita, T; Sasaki, R; Sato, N; Suzuki, M; Tamura, M; Yamada, M, 2002) |
| "We evaluate 1,271 patients from the Thrombolysis in Myocardial Infarction (TIMI)-IIIB trial (86% of TIMI-IIIB cohort) with unstable angina or non-Q wave myocardial infarction, who underwent predischarge exercise (92%) or dipyridamole stress (8%) Tl-201 imaging." | 3.69 | Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study. ( Jain, D; Thompson, B; Wackers, FJ; Zaret, BL, 1997) |
| "In this study, we investigated the antinephritic effects of TJ-8014 and crude drugs in TJ-8014, in comparison to dipyridamole, on original-type anti-GBM nephritis in rats." | 3.67 | Studies on antinephritic effect of TJ-8014, a new Japanese herbal medicine, and its mechanisms (1): Effects on original-type anti-GBM nephritis in rats and platelet aggregation. ( Hattori, T; Ito, M; Nagamatsu, T; Suzuki, Y, 1989) |
| "Five aspirin preparations were evaluated, 3 different enteric-coated 75-mg aspirins, dispersible aspirin 75 mg and asasantin (25-mg standard release aspirin plus 200-mg modified-release dipyridamole given twice daily)." | 2.72 | Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. ( Byrne, MF; Conroy, R; Cox, D; Dooley, M; Fitzgerald, DJ; Maree, AO, 2006) |
| "Therefore, glibenclamide treatment of Type 2 diabetes mellitus may have hazardous cardiovascular effects when used under conditions of ischaemia." | 2.70 | Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients. ( Abbink, EJ; Jansen van Rosendaal, A; Lutterman, JA; Pickkers, P; Russel, FG; Smits, P; Tack, CJ, 2002) |
| " Proportional dosing resulted in decreasing CNR, SNR, and visual IQS with increasing body weight (P < 0." | 1.91 | Exponential dosing to standardize myocardial perfusion image quality with rubidium-82 PET. ( Beanlands, RSB; deKemp, RA; Khetarpal, R; Tavoosi, A; Wells, RG, 2023) |
| "Dipyridamole treatment prevented the development of abnormal left ventricular chamber filling, preserved adrenergic responsiveness and appeared to attenuate detrimental chamber remodeling in rats with pressure overload hypertrophy." | 1.30 | Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. ( Aurigemma, GP; Chung, ES; Dobson, JG; Fenton, RA; Meyer, TE; Perlini, S, 1998) |
| "Furthermore." | 1.30 | Valsartan and coronary haemodynamics in early post-myocardial infarction in rats. ( De Gasparo, M; Fornes, P; Gervais, M; Giudicelli, JF; Richer, C, 1999) |
| "The mean value of the thrombus area in the dilazep group was 60% smaller and the distribution pattern of the thrombus by size was found to be composed of smaller thrombi than those of the control group." | 1.28 | Thrombus formation on the aorta injured by angioplasty and its prevention with dilazep in atherosclerotic rabbits. ( Asanuma, A; Fujii, M; Nobuyoshi, M; Takimoto, M; Tanaka, M, 1989) |
| " In addition, treatment with dipyridamole also reduced the growth inhibitory effects of cytarabine on HL-60 cells in culture and protected mice from toxic doses of this antimetabolite." | 1.27 | Modulation of cytarabine uptake and toxicity by dipyridamole. ( Howell, SB; King, ME; Naporn, A; Young, B, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (57.14) | 18.7374 |
| 1990's | 7 (25.00) | 18.2507 |
| 2000's | 4 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Tavoosi, A | 1 |
| Khetarpal, R | 1 |
| Wells, RG | 1 |
| Beanlands, RSB | 1 |
| deKemp, RA | 1 |
| Yamada, M | 1 |
| Sasaki, R | 1 |
| Sato, N | 1 |
| Suzuki, M | 1 |
| Tamura, M | 1 |
| Matsushita, T | 1 |
| Kurumatani, H | 1 |
| Chen, P | 1 |
| Chien, PY | 1 |
| Khan, AR | 1 |
| Sheikh, S | 1 |
| Ali, SM | 1 |
| Ahmad, MU | 1 |
| Ahmad, I | 1 |
| Cox, D | 1 |
| Maree, AO | 1 |
| Dooley, M | 1 |
| Conroy, R | 1 |
| Byrne, MF | 1 |
| Fitzgerald, DJ | 1 |
| Tornling, G | 4 |
| Adolfsson, J | 4 |
| Unge, G | 3 |
| Ljungqvist, A | 3 |
| King, ME | 1 |
| Naporn, A | 1 |
| Young, B | 1 |
| Howell, SB | 1 |
| Carlsson, S | 2 |
| Tomanek, RJ | 2 |
| Barlow, PA | 1 |
| Connell, PM | 1 |
| Chen, Y | 1 |
| Torry, RJ | 1 |
| Hofer, M | 1 |
| Pospísil, M | 1 |
| Netíková, J | 1 |
| Znojil, V | 1 |
| Vácha, J | 1 |
| Holá, J | 1 |
| Kwok, CG | 1 |
| Wu, S | 1 |
| Tsang, HP | 1 |
| Strauss, HW | 1 |
| Jain, D | 1 |
| Thompson, B | 1 |
| Wackers, FJ | 1 |
| Zaret, BL | 1 |
| Chung, ES | 1 |
| Perlini, S | 1 |
| Aurigemma, GP | 1 |
| Fenton, RA | 1 |
| Dobson, JG | 1 |
| Meyer, TE | 1 |
| Gervais, M | 1 |
| Richer, C | 1 |
| Fornes, P | 1 |
| De Gasparo, M | 1 |
| Giudicelli, JF | 1 |
| Abbink, EJ | 1 |
| Pickkers, P | 1 |
| Jansen van Rosendaal, A | 1 |
| Lutterman, JA | 1 |
| Tack, CJ | 1 |
| Russel, FG | 1 |
| Smits, P | 1 |
| Skoog, L | 1 |
| Okada, N | 1 |
| Aizawa, T | 1 |
| Yokokawa, N | 1 |
| Kobayashi, M | 1 |
| Moriya, T | 1 |
| Shigematsu, S | 1 |
| Shirota, T | 1 |
| Komatsu, M | 1 |
| Shinoda, T | 1 |
| Yamada, T | 1 |
| Chilian, WM | 1 |
| Wangler, RD | 1 |
| Peters, KG | 1 |
| Marcus, ML | 1 |
| Clozel, JP | 1 |
| Hefti, F | 1 |
| Nobuyoshi, M | 1 |
| Tanaka, M | 1 |
| Fujii, M | 1 |
| Asanuma, A | 1 |
| Takimoto, M | 1 |
| Hattori, T | 1 |
| Nagamatsu, T | 1 |
| Ito, M | 1 |
| Suzuki, Y | 1 |
| Camp, A | 1 |
| Chaitman, BR | 1 |
| Goodgold, H | 1 |
| Byers, S | 1 |
| Shaw, L | 1 |
| Barth, G | 1 |
| Samuels, L | 1 |
| Verbeuren, TJ | 1 |
| Coene, MC | 1 |
| Jordaens, FH | 1 |
| Van Hove, CE | 1 |
| Zonnekeyn, LL | 1 |
| Herman, AG | 1 |
| Triebe, G | 1 |
| Blass, KE | 1 |
| Förster, W | 1 |
| Kobayakawa, T | 1 |
| Takenaka, F | 1 |
| Takeya, N | 1 |
| Ishihara, T | 1 |
| Higuchi, M | 1 |
| Hayashi, H | 1 |
| Ando, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Enteric Coating as a Factor in Aspirin Resistance[NCT00531362] | 250 participants (Actual) | Observational | 2007-09-30 | Completed | |||
| [NCT00000472] | Phase 3 | 0 participants | Interventional | 1989-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for dipyridamole and Body Weight
| Article | Year |
|---|---|
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.
Topics: Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Body Weight; Cross-Over Studies; Dipyridamol | 2006 |
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients.
Topics: Acetylcholine; Adult; Aged; Blood Flow Velocity; Blood Pressure; Body Mass Index; Body Weight; C-Pep | 2002 |
26 other studies available for dipyridamole and Body Weight
| Article | Year |
|---|---|
Exponential dosing to standardize myocardial perfusion image quality with rubidium-82 PET.
Topics: Body Weight; Coronary Artery Disease; Dipyridamole; Humans; Myocardial Perfusion Imaging; Positron-E | 2023 |
Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Blood Pressure; Blood U | 2002 |
In-vitro and in-vivo anti-cancer activity of a novel gemcitabine-cardiolipin conjugate.
Topics: Animals; Antineoplastic Agents; Body Weight; Cardiolipins; Cell Proliferation; Deoxycytidine; Dipyri | 2006 |
Capillary neoformation in skeletal muscle of dipyridamole-treated rats.
Topics: Animals; Body Weight; Capillaries; Dipyridamole; Male; Muscles; Neovascularization, Pathologic; Rats | 1980 |
Modulation of cytarabine uptake and toxicity by dipyridamole.
Topics: Animals; Biological Transport; Body Weight; Cell Line; Cytarabine; Dipyridamole; Drug Evaluation, Pr | 1984 |
Capillary neoformation in the heart and skeletal muscle during dipyridamole--treatment and exercise.
Topics: Animals; Body Weight; Capillaries; Cell Division; Coronary Vessels; Dipyridamole; DNA Replication; F | 1982 |
Proliferative activity of capillary wall cells in skeletal muscle of rats during long-term treatment with dipyridamole.
Topics: Aging; Animals; Autoradiography; Body Weight; Capillaries; Cell Division; Dipyridamole; DNA; Female; | 1980 |
Effects of hypothyroidism and hypertension on myocardial perfusion and vascularity in rabbits.
Topics: Animals; Arterioles; Blood Pressure; Body Weight; Coronary Circulation; Coronary Vessels; Dipyridamo | 1993 |
Radioprotective efficacy of dipyridamole and AMP combination in fractionated radiation regimen, and its dependence on the time of administration of the drugs prior to irradiation.
Topics: Adenosine Monophosphate; Animals; Body Weight; Cell Division; Dipyridamole; Drug Administration Sche | 1995 |
Feasibility of simultaneous dual-isotope myocardial perfusion acquisition using a lower dose of sestamibi.
Topics: Body Weight; Coronary Disease; Dipyridamole; Exercise Test; Feasibility Studies; Female; Heart; Huma | 1997 |
Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study.
Topics: Angina, Unstable; Body Weight; Cardiac Catheterization; Dipyridamole; Exercise Tolerance; Female; Fo | 1997 |
Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat.
Topics: Adenosine; Animals; Blood Pressure; Body Weight; Dipyridamole; Heart; Hypertrophy, Left Ventricular; | 1998 |
Valsartan and coronary haemodynamics in early post-myocardial infarction in rats.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Body Weigh | 1999 |
Proliferative activity of myocardial capillary wall cells in dipyridamole--treated rats.
Topics: Animals; Body Weight; Capillaries; Cell Division; Coronary Vessels; Dipyridamole; Female; Heart; Mal | 1978 |
Abnormal molecular weight profile of urinary protein in rats with streptozotocin-induced diabetes.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dipyridamole; Electrophoresis, | 1992 |
Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Body Weight; Capillaries; Cardiomegaly; Coronary Circu | 1985 |
Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Cilazapril; Coronary C | 1988 |
Thrombus formation on the aorta injured by angioplasty and its prevention with dilazep in atherosclerotic rabbits.
Topics: Angioplasty, Balloon; Animals; Aorta; Arteriosclerosis; Azepines; Body Weight; Cholesterol; Dilazep; | 1989 |
Studies on antinephritic effect of TJ-8014, a new Japanese herbal medicine, and its mechanisms (1): Effects on original-type anti-GBM nephritis in rats and platelet aggregation.
Topics: Animals; Antibodies; Basement Membrane; Blood Urea Nitrogen; Body Weight; Dipyridamole; Drugs, Chine | 1989 |
Intravenous dipyridamole: body weight considerations and dosage requirements.
Topics: Adult; Aged; Body Weight; Coronary Disease; Dipyridamole; Dose-Response Relationship, Drug; Exercise | 1989 |
Time dependence of dipyridamole-induced increase in skeletal muscle capillarization.
Topics: Animals; Body Weight; Capillaries; Dipyridamole; Heart; In Vitro Techniques; Male; Muscles; Organ Si | 1986 |
Effect of hypercholesterolemia on vascular reactivity in the rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Dipyridamole; Hype | 1986 |
[Influence of long-term treatment with dipyridamole on the contractility and development of hypertrophy in rabbit heart with aortic stenois].
Topics: Animals; Aortic Valve Stenosis; Blood Pressure; Body Weight; Cardiomegaly; Dipyridamole; Female; Hea | 1972 |
[Experimental study on drugs for the treatment of myocardial infarction].
Topics: Angiography; Animals; Benzyl Compounds; Body Weight; Carboxylic Acids; Dipyridamole; Disease Models, | 1972 |
Toxicological studies on dipyridamole in the rat.
Topics: Administration, Oral; Animals; Body Weight; Dipyridamole; Feeding Behavior; Female; Injections, Intr | 1972 |
[Experimental studies on selective coronary artery infusion].
Topics: Angiocardiography; Animals; Blood Pressure; Body Weight; Coloring Agents; Contrast Media; Coronary A | 1968 |